April 2012 Introduction to Multiple Sclerosis and the MS Center, an interview with Karen Wenzel and Dr. Vollmer. Dr. Vollmer and Karen Wenzel Audio = Download 1st MP3 here. Dr. Vollmer…
Invisible Symptoms of MS: Cognition, Fatigue and DepressionApril 24, 2010If you missed our last seminar or did not get a copy of the slides, you can view and/or print the…
John R. Corboy, M.D., Professor of Neurology, University of Colorado Denver, School of Medicine, is Co-Director of the Rocky Mountain MS Center at Anschutz Medical Campus. Born in Chicago, Dr….
Augusto Miravalle, M.D. completed his neurology residency at the Loyola University Medical Center where he served as Chief Resident. He completed his second year of postdoctoral fellowship at the Beth…
Teri Schreiner, MD MPH, completed medical school at the University of Rochester in Rochester, NY after working in healthcare consulting. Teri completed residency in Pediatric Neurology at the University of…
With the recent announcement confirming the increased number of PML cases, other information has become available as well. Of the 24 cases, two-thirds have been in Europe and one-third in…
The materials and information on the MS Center website are intended for educational and informational purposes only. The materials and information are not intended to replace the services of a…
The diagnosis of “secondary progressive MS” has long been thought to mark a shift in the course of the disease from a primarily inflammatory process to a neurodegenerative one. Although the majority of people with…
Cladribine is an FDA approved chemotherapy treatment most often used to treat leukemia and lymphoma. By mid-2009, however, the therapy will likely head to the FDA and European EMEA for…